by Jessica Casebolt | Feb 28, 2023 | Life Sciences, Tea Leaves
The misuse of antibiotics during the COVID-19 pandemic points to a need for provider systems to shore up their antimicrobial stewardship programs, according to experts at the Centers for Disease Control & Prevention. A new research letter in the Journal of the...
by Jessica Casebolt | Feb 21, 2023 | Life Sciences, Tea Leaves
The United Network for Organ Sharing, the nonprofit managing the country’s organ transplant system, is pushing for policy changes to make the transportation of organ donations more seamless. Interim CEO Maureen McBride wants organ transit via commercial air to revert...
by Jordana Choucair | Feb 10, 2023 | Life Sciences
The Biden administration released proposed guidance that outlines the first of a pair of major drug price reforms contained in the Inflation Reduction Act. The initial guidance documents for both physician-administered and pharmacy drugs offer details about the...
by Jordana Choucair | Feb 10, 2023 | Life Sciences
The Senate Judiciary Committee approved via voice vote five bipartisan drug pricing bills that could go before the full Senate soon. One of the bills would limit anticompetitive “pay-for-delay” deals that prevent or delay the introduction of affordable follow-on...
by Jordana Choucair | Feb 7, 2023 | Life Sciences
Senate Finance Committee Chairman Ron Wyden vowed that Democrats intend to protect Medicare drug price negotiation measures passed last year as part of the Inflation Reduction Act and that the pharmaceutical industry is targeting. Wyden said during an event that...
by Jordana Choucair | Feb 6, 2023 | Life Sciences
A Wall Street Journal article examines how Amazon’s new RxPass prescription service and Mark Cuban’s Cost Plus Drug Co. are increasing the downward pressure on the cost of generic drugs. The competition from both entities has instigated more established players...
Recent Comments